Study to Investigate the Activity of AZD5122 When Given as a Single Dose to Healthy Male Subjects

NCT00984477 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: AZD5122
DRUG: Placebo
DRUG: AZD5122

Sponsor

AstraZeneca